Skip to main content

Main navigation

  • Schizophrenia Foundations
  • Symptomatology
  • Patient Burden
  • Caregiver Perspectives
  • Psychopharmacology

Main navigation

  • Schizophrenia Foundations
  • Symptomatology
  • Patient Burden
  • Caregiver Perspectives
  • Psychopharmacology

Psychopharmacology

Medication in hand
Navigating the A to Z of Schizophrenia, Part 3: Novel Treatment Mechanisms

Welcome to Schizophrenia Knowledge Base

This website is intended for healthcare professionals in the United States.

Yes, I am a US healthcare professional
No, I am not a US healthcare professional
Medication
CME: Psychopharmacolojourney: A Look at How Far We Have Come and Where We Might Go
Patient and provider
Schizophrenia Unfiltered, Part 3: Pathways to Novel Treatment 
Ins and Outs title slide
Ins and Outs of Antipsychotic Therapy for Schizophrenia
Prescribing
End of the Anticholinergic Era? Rationale and Evidence-Based Strategies for Deprescribing
Research
CME: The Next Generation of Schizophrenia Treatment: Looking Beyond D2 and Exploring Novel Therapeutic Targets
Laboratory researcher
Overcoming Challenges in Schizophrenia Treatment
Neuron
New Mechanisms of Action in Psychiatry
Pharmacist
Developments in Treating Schizophrenia: New Mechanisms of Action and Methods of Delivery
Patient and provider
Innovative Pathways in Schizophrenia Treatment
Medication
Treatment Options and Managing Side Effects in Schizophrenia

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 1
  • Current page 2
  • Page 3
  • Next page Next ›
  • Last page Last »
© 2025 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use Cookie Policy